Antioxidant factors, such as glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD), have been considered therapeutic targets that inhibit AD pathogenesis (Chen et al., 2019). The gene discussed is SOD1; the disease is Alzheimer disease.